GeneReach Biotechnology Corp. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was TWD 187.418 million compared to TWD 155.411 million a year ago. Operating income was TWD 11.376 million compared to operating loss of TWD 21.419 million a year ago. Net income was TWD 28.571 million compared to net loss of TWD 48.125 million a year ago. Basic earnings per share was TWD 0.83 compared to basic loss per share of TWD 1.4 a year ago. Diluted earnings per share was TWD 0.78 compared to diluted loss per share of TWD 1.4 a year ago.